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Deep brain stimulation (DBS) of the bilateral subthalamic nucleus (STN) in Parkinson’s disease is thought to
produce adverse events such as emotional disorders, and in a recent study, we found fear recognition to be
impaired as a result. These changes have been attributed to disturbance of the STN’s limbic territory and
would appear to confirm that the negative emotion recognition network passes through the STN. In addition,
it is now widely acknowledged that damage to the orbitofrontal cortex (OFC), especially the right side, can
result in impaired recognition of facial emotions (RFE). In this context, we hypothesized that this reduced recog-
nition of fearis correlatedwith modificationsinthe cerebralglucose metabolism oftheright OFC.The objective
of the present study was first, to reinforce our previous results by demonstrating reduced fear recognition in our
Parkinson’s disease patient group following STN DBS and, second, to correlate these emotional performances
with glucose metabolism using
18FDG-PET. The
18FDG-PETand RFE tasks were both performed by a cohort
of 13 Parkinson’s disease patients 3 months before and 3 months after surgery for STN DBS. As predicted,
we observed a significant reduction in fear recognition following surgery and obtained a positive correlation
between these neuropsychological results and changes in glucose metabolism, especially in the right OFC.
These results confirm the role of the STN as a key basal ganglia structure in limbic circuits.
Keywords: subthalamic nucleus deep brain stimulation;
18FDG-PET; Parkinson’s disease; emotion recognition; orbitofrontal
cortex
Abbreviations: DBS=deep brain stimulation; OFC=orbitofrontal cortex; RFE=recognition of facial emotions;
SPM=statistical parametric mapping; STN=subthalamic nucleus
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Introduction
Deep brain stimulation (DBS) of the subthalamic nucleus
(STN), a small structure within the brain, is recognized as
a treatment of choice for patients with medically intractable
Parkinson’s disease (Limousin-Dowsey et al., 1999; Krack
et al., 2002).
Although this treatment appears to have a low morbidity
rate and despite manifest improvements in motor perfor-
mance after surgery, some behavioural disturbances have
been reported. In particular, anxiety, mood disorders,
apathy, indifference, personality changes, modified control
of emotional responses and affective blunting have been
observed in a small cohort of patients (Saint-Cyr et al.,
2000; Trepanier et al., 2000; Bejjani et al., 2002; Houeto
et al., 2002; Drapier et al., 2006). Cognitive functions would
also appear to be affected by chronic bilateral stimulation.
According to Temel’s review, the three most important
behavioural changes after STN DBS are cognitive dysfunc-
tions (41% of patients), depression (8%) and mania (4%)
(Temel et al., 2006). The most frequently reported adverse
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et al., 2000).
These neuropsychological modifications induced by STN
DBS suggest that this neurosurgery may disturb the func-
tioning of associative and limbic circuits: neuroanatomical
studies in animals have already demonstrated that the STN
can be divided into sensorimotor (dorsolateral), limbic
(medial) and cognitive-associative (ventromedial) areas
(Parent and Hazrati, 1995; Joel and Weiner, 1997). Thus,
although the target of surgery is the motor area, the adverse
neuropsychological effects suggest that the other two areas
may be affected by current diffusion (Dujardin et al., 2004b).
Some neuroimaging studies using
15O-H2O-PET have
confirmed these hypotheses by demonstrating modifications
in brain activation associated with neuropsychological
impairments following STN DBS. One PET study showed
decreased activity in both the right anterior cingulate cortex
and the right ventral striatum during a response conflict
task (Stroop task) (Schroeder et al., 2002). In a second
study, Schroeder et al. (2003) reported decreased activity in
the right orbitofrontal cortex (OFC), the left temporal gyrus
and the left inferior frontal/insular cortex, associated with
poorer performances on verbal fluency and counting tasks
(Schroeder et al., 2003).
Dujardin et al. (2004b) and Schroeder et al. (2003) have
both reported reduced recognition of negative facial emotions
following STN DBS, and more recently our own group
(Biseul et al., 2005) demonstrated that the surgery can induce
selective fear recognition impairment. Damage to the OFC
can result in impaired recognition of facial expressions
(Adolphs, 2002a, b), and the STN is indeed closely connected
to the OFC (Canteras et al., 1990). Accordingly, in the present
study, we hypothesized that the impaired recognition of
fear in Parkinson’s disease patients following STN DBS is
correlated with modifications in the glucose metabolism of
the OFC. To test this hypothesis we conducted a
18F-FDG-
PET study of 13 Parkinson’s disease patients in pre- and post-
STN DBS conditions and correlated changes in their glucose
metabolism with modified performances on a recognition
of facial emotion (RFE) task.
Participants and Methods
Participants
One group of patients with Parkinson’s disease and one healthy
control (HC) group took part in the study. All patients met
the clinical criteria of the United Kingdom Parkinson’s Disease
Society Brain Bank for idiopathic Parkinson’s disease (Hughes
et al., 1992).
The patient group consisted of a series of 13 consecutive
patients with medically intractable Parkinson’s disease, who
underwent bilateral STN DBS at Rennes University Hospital
(France). Standard selection and exclusion criteria for surgery
were applied to all patients (Welter et al., 2002). In particular,
brain atrophy was excluded on the basis of the preoperative MRI.
There were nine men and four women. Mean (SD) age at
surgery was 57 (7.8) years. All 13 Parkinson’s disease patients
were right-handed, according to the criteria of the Edinburgh
Handedness Inventory (Oldfield, 1971). Mean (SD) disease
duration at surgery was 10.9 (2.2) years. The total levodopa-
equivalent dose was calculated on the basis of the following
correspondences adapted from (Lozano et al., 1995): mean (SD)
1066.2mg (347) before STN DBS and 957.3mg (494.6) after
STN DBS.
The HC group consisted of 30 healthy individuals who had no
history of neurological disease, head injury or alcohol abuse and
displayed no signs of dementia, as attested by their scores on the
MMSE (De ´rouesne ´, 2001).
The two groups were matched for age, sex ratio, handedness
and education level. After a complete description of the study,
written informed consent was obtained for each participant, and
the study was conducted in accordance with the declaration
of Helsinki.
Methods
All the patients were assessed 3 months before and 3 months
after surgery, using motor, PET and neuropsychological assess-
ments. These evaluations were all performed in the same week.
All the patients were on stimulation and on dopa for the PET and
neuropsychological evaluations.
Prior to the STN DBS, all patients were neuropsychologically
assessed to rule out cognitive impairments, using the Mattis scale
(Mattis, 1988) and executive tasks, and depression, using the
Montgomery and Asberg Depression Rating Scale, (MADRS)
(Montgomery and Asberg, 1979). Following surgery, they were
followed up clinically by a movement disorder specialist. None of
the patients included in this study suffered from dementia [Mattis:
mean (SD)=139.8 (2.4)] or depression [MADRS: mean
(SD)=4.2 (6.4)].
Motor evaluations
All patients were evaluated according the Core Assessment
Program for Intracerebral Transplantation (Langston et al.,
1992) and were scored on the Unified Parkinson’s Disease
Rating Scale (UPDRS) I–IV (Fahn and Elton, 1987), the Hoehn
and Yahr score (Hoehn and Yahr, 1967) and the Schwab and
England score (Schwab and England, 1969) 3 months before and
3 months after surgery. Patients were assessed on and off dopa
before and after surgery. Stimulation remained on after surgery.
Neurosurgery
Methodology. Quadripolar (from ‘0’ for the most ventral contact
to ‘3’ for the most dorsal one) DBS electrodes (3389 Medtronic,
Minneapolis, MN, USA) were implanted bilaterally in the sub-
thalamic nucleus in two successive operating sessions. The overall
methodology was similar to that previously described by Benabid
et al. (2000). The location of the two selected electrode contacts
(one on the left and one on the right) was determined using the
stereotactic coordinates of the ventriculogram performed at the
onset of the surgical procedure. During the operation, the final
course and depth of the electrode were determined by the best
effect obtained on rigidity with no side effect and at the lowest
voltage. A 3D CT brain scan performed a few days later confirmed
the position of the electrodes.
Electrode location. The contacts’ coordinates were expressed as
millimetres along three axes originating from the middle of the
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line, the second axis was perpendicular to the anterior commis-
sure–posterior commissure line and the third axis was perpendic-
ular to the midsagittal plane. The mean coordinates of the selected
contacts were 11.81.4mm lateral to the anterior commissure–
posterior commissure line, 0.82.1mm below the anterior
commissure–posterior commissure and 1.11.6mm posterior to
the middle anterior commissure–posterior commissure. In all
patients, chronic stimulation was monopolar, using a single
contact of the quadripolar electrode. The stimulation character-
istics were as follows: mean pulse width 64.6ms for the right side
(SD=11.2) and 64.6ms (SD=11.2) for the left side, mean
frequency 135.3Hz (SD=15.4) for the right side and 136.5Hz
(SD=15.6) for the left side and mean voltage 2.3V (SD=0.6) for
the right side and 2.4V (SD=0.6) for the left side. The stimu-
lation characteristics for each patient are set out in Table 1.
Neuropsychological and RFE assessments
Neuropsychological background. A short neuropsychological bat-
tery was administered to all subjects before the RFE session(s).
This battery included the Mattis scale (Mattis, 1988) and a series
of tests assessing frontal executive functions: the Nelson simplified
version of the Wisconsin Card Sorting Test (Nelson, 1976), the
Trail Making Test (Reitan, 1958), Category and Literal Fluency
Test (Cardebat et al., 1990) and the Stroop Test (Stroop, 1935).
Benton Facial Recognition Test. To ensure that the early
processing stages of face perception were intact, the Benton Facial
Recognition Test (Benton et al., 1983) was administered to all
subjects before the RFE session(s). Subjects were excluded from
the study, if face recognition as measured by the Benton Recog-
nition Test was impaired.
RFE. After familiarizing themselves with the task and the list of
emotions, the subjects were presented with a randomized sequence
of 55 computerized photographic slides of seven facial expressions
(happiness, sadness, fear, surprise, disgust, anger and no emotion)
on a screen (Ekman and Friesen, 1976). After observing a picture
for 3s, the subjects were prompted to give an answer by choos-
ing the most suitable response among the seven expressions.
The percentage of correct responses was calculated for each of the
seven emotions as well as for the total score.
PETimaging procedure
All subjects were studied using
18F-FDG PET in a resting state
with eyes open. They underwent two scans: the first was perfor-
med 3 months before surgery and the second 3 months after
surgery, with the stimulator switched on and on their anti-
parkinsonian medication.
PET measurements were performed using a dedicated Discovery
ST PET scanner (GEMS, Milwaukee, USA) in 2D mode with an
axial field of view of 15.2cm.
A 222–296 MBq injection of
18F-FDG was administered intra-
venously under standardized conditions (in a quiet, dimly lit room
with the patient’s eyes and ears open). During acquisition, the
patient’s head was immobilized using a head holder. A cross-laser
system were used to achieve stable and reproducible positioning.
A 20min 2D emission scan was performed 30min post-injection
and after X-ray-based attenuation correction. These studies were
performed with the subjects positioned at the centre of the field of
view. Following scatter, dead time and random corrections, PET
images were reconstructed by 2D filtered back projection, providing
47 contiguous transaxial 3.75mm thick slices.
PET image transformation
The data were analysed using SMP2 software (Wellcome Depart-
ment of Cognitive Neurology, London, UK) implemented in
MATLAB, Version 7 (Mathworks Inc., Sherborn, MA). Statistical
parametric maps are spatially extended statistical processes that
are used to characterize specific regional effects in imaging data.
It combines the general linear model (to create the statistical map)
with Gaussian field theory in order to draw statistical inferences
about regional effects (Friston et al., 1995).
All the subjects’ images were first realigned and spatially
normalized into standard stereotactic space according to Talairach
and Tournoux’s atlas (Talairach and Tournoux, 1988). This
normalizing spatial transformation matched each scan to our
own specially created
18F-FDG template image, which already
conformed to the standard space. In effect, in order to optimize
Table 1 Stimulator parameters for each patient [electrodes: stimulated ()c o n t a c t s ]
Subjects Electrodes Frequency (Hz) Amplitude (V) Impulse duration (ms)
Right Left Right Left Right Left Right Left
12  1 130 130 2.2 3.3 60 60
21  1 130 130 1.6 1.6 60 60
32  2 130 130 2.6 2.6 60 60
41  2 185 185 3 3 60 60
52  1 130 130 3 3 60 60
61  1 130 130 3 2.5 60 60
72  2 130 130 2.5 1.8 90 90
81  1 145 145 2.2 2.3 60 60
91  2 130 145 1.3 2 60 60
10 2 3 130 130 3 3 90 90
11 2 2 130 130 2.8 2.8 60 60
12 0 1 130 130 1.3 1.8 60 60
13 1 1 130 130 2 2 60 60
Hz = hertz; V = volts; ms = microseconds.
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15O-H2O
template provided in the statistical parametric mapping (SPM)
software package, in line with Gispert et al. (2003), we created our
own
18F-FDG template, using the images of 15 control subjects
acquired in the same injection, acquisition and reconstruc-
tion conditions. We were able to use this template because our
Parkinson’s disease patients did not present any atrophy, as
attested by the preoperative MRI.
An affine transformation was performed to determine the
12 optimum parameters for registering the brain images on the
template and the subtle differences between the transformed image
and the template were then removed using a non-linear registra-
tion method. Finally, spatially normalized images were smoothed
using an isotropic 12mm full width at half-maximum isotropic
Gaussian kernel to compensate for inter-individual anatomical
variability and render the imaging data more normally distributed.
Statistical analysis
Neuropsychological and emotional data. Because of the small
number of subjects and the considerable variance within the
patient group, non-parametric analyses were carried out.
For the inter-group comparisons, paired comparisons were
performed using the non-parametric Mann–Whitney U-test for
two independent groups.
For the intra-group comparisons, Wilcoxon’s test for paired
groups was used to evaluate the effect of the experimental con-
dition (before versus after surgery). P-values 50.05 were consid-
ered to be significant.
Correlation studies. (i) First step: The effects of global metabo-
lism were removed by normalizing the count of each voxel to the
total brain count (proportional scaling in SPM). Then significant
changes of regional cerebral metabolism in the 13 Parkinson’s
disease patients were estimated by comparing their PET images in
pre- and post-operative on-stimulation conditions using a t-test
at every voxel. Clusters of a minimum of 100 contiguous voxels,
with a threshold of two-tailed P50.005 (corrected for multiple
comparison), were considered to be significantly different.
(ii) Second step: The SPM software established correlations
between post- versus pre-operative changes in the fear RFE score
and post- versus pre-operative changes in brain glucose metabolism.
To identify, which regions correlated significantly with impaired fear
recognition, a general linear ‘single subject, covariates only’ model
was tested at each voxel, with the fear RFE score as a covariant.
This yielded a regression coefficient, which was then transformed
into a t-value.
Two t-tests were performed: there was a positive correlation
when decreased fear RFE scores (poor performances) were asso-
ciated with decreased voxel values, and a negative correlation
when decreased fear RFE scores (poor performances) were asso-
ciated with increased voxel values.
T-statistics SPMs were then calculated and thresholded at
P50.005, with multiple comparison correction (k4100).
All coordinates reported here are based on the Talairach atlas
and were transformed by applying procedures developed by
Matthew Brett (http://www.mrc-cbu.cam.ac.uk/Imaging).
Results
Clinical and motor results
A significant motor improvement was observed 3 months
after surgery, as shown by the changes in the motor
UPDRS, the Hoehn and Yahr and the Schwab and England
scores. Table 2 shows the effects of surgery on the motor
symptoms.
Neuropsychological and RFE results
Neuropsychological background and Benton Facial
RecognitionTest
The neuropsychological backgrounds of all subjects and
their Benton Facial Recognition Test data are presented in
Table 3.
Inter-group comparisons. In the preoperative condition, no
significant difference was found between the neuropsycho-
logical backgrounds of the STN and HC groups (all
measures P40.2), except for the number of errors and
perseverations on the Modified Wisconsin Card Sorting
Test (P=0.01 and P=0.01, respectively).
In the postoperative condition, no significant difference
was found between the neuropsychological backgrounds of
the STN and HC groups (all measures P40.1), except for
the Interference score on the Stroop test (P=0.003).
Intra-group comparisons. In Parkinson’s disease patient
group, no significant difference was found between the pre-
and post-operative conditions for the neuropsychological
background tests. It should be noted that analyses revealed
a trend towards significance (P=0.07) between the pre- and
Table 2 Motor scores (meanSD) before (preoperative condition, baseline) and after (postoperative condition, M+3)
STN DBS in Parkinson’s disease patients
Off-dopa period score On-dopa period score
Preoperative (baseline) Postoperative (M+3) Preoperative (baseline) Postoperative (M+3)
MeanSD Mean SD Mean SD Mean SD
UPDRS III 28.8 9.1 18.2 8.3
 7.1 3.8 7.5 4.7
Schwab and England (%) 6521.5 76.1 11.2 9 0  68 8 . 4 10.7
Hoehn and Yahr 2.31.0 2.2 0.8 1 0.6 1.1 1
Differential effects between the two conditions are reported (Wilcoxon’s test for paired comparisons).
P50.05.UPDRS = united PD rating scale; SD = standard deviation.
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Stroop test.
RFE
Inter-group comparisons. No significant difference was
found in the pre- and post-operative conditions between
the STN and HC groups for RFE (P40.1), either for each
of the six emotions or for the overall score.
Intra-group comparisons. Total RFE was significantly
impaired following STN DBS, compared with the pre-
operative assessment (P=0.008). This was due to a signif-
icant selective reduction in RFE for fear (P50.05).
The RFE data for the Parkinson’s disease patient group
and the HC group are presented in Table 4.
Cerebral metabolic results
First step: differences between pre- versus post-operative
on-stimulation conditions
Areas of significant differences found by comparing the
patients in pre- and post-operative on-stimulation condi-
tions are shown in Fig. 1.
In our analysis of postoperative decreases in metabo-
lism, four clusters were significant at level P50.005 with
correction for multiple comparison. Hypometabolism
was observed in the bilateral limbic lobe, cingulate gyrus
[Brodmann areas (BA) 24, BA 33)], right superior frontal
gyrus (BA 8 and 9), right pre-central gyrus (BA 6),
right middle frontal gyrus (BA 46) and right superior
temporal gyrus (BA 42).
When we studied postoperative increases in metabolism,
two clusters were significant at level P50.005, with
multiple comparison correction.
Hypermetabolism was observed in the bilateral cerebel-
lum and right fusiform gyrus (BA 19).
Second step: correlations studies
Positive correlation between changes of glucose metabolism
and impairment of fear recognition. All significant findings
obtained by positively correlating changes in glucose metab-
olism with modified cognitive performances are summarized
in Table 5, together with their Talairach coordinates.
Positive correlations were observed in two significant
clusters (P50.005, multiple comparison correction). The
first cluster concerned the bilateral frontal lobe, orbital
gyrus (right BA 10 and right and left BA 11), predomi-
nantly in the right side. The second cluster included the
middle and inferior frontal gyri (right and left BA 47, left
BA 46, left 45) (Figs 2 and 3).
Negative correlation between changes in glucose metabo-
lism and impairment of fear recognition. All significant
findings obtained by negatively correlating changes in
glucose metabolism with modified cognitive performances
are summarized in Table 6.
Negative correlations were observed in two significant
clusters (P50.005, corrected for multiple comparison), in
the right posterior cerebellum and right temporal lobe (BA
22, 39, 40). The amygdala were seen as a small significantly
negatively correlated cluster (k=40) (P50.005 corrected
for multiple comparison) (Fig. 4).
Discussion
The aim of this article was to correlate RFE abilities,
especially fear recognition, with modifications in cerebral
Table 3 Neuropsychological background data (meanSD)
before (preoperative condition, baseline) and after
(postoperative condition, M+3) STN DBS in Parkinson’s
disease patients
Preoperative
condition
(baseline)
Postoperative
condition
(M+3)
HC group
MeanSD Mean SD Mean SD
Benton (/54) 46.43.7 47 44 6 . 5 4.6
Mattis (/144) 139.82.4 138.93.4 140.7 1.6
Stroop test
interference
2.67.3 2.4
 6.5 3.14.8
TMT (s) B^A 77.657.8 64.342.3 70.529.3
Verbal fluency
Categorical 23.29.9 21.7 8.6 26.4 8.9
Phonemic 20.8 8.9 21.611.6 19.7 6.4
MCST
Number of
categories
5.6 0.4 5.5 0.9 5.8  0.3
Number of errors 6.6
3.9 5.3 52 . 7 2.9
Number of
perseverations
1.9
1.4 1.6 2.2 0.61
MADRS 4.16.3 4.25.3 ^
P50.01when compared with HC group (Mann-Whitney test).
TMT = Trail MakingTest; MCST = Modified Wisconsin Card
SortingTest; MADRS = Montgomery-Asberg Depression Scale;
SD = standard deviation.
Table 4 Percentage of correct RFE (meanSD) before
(preoperative condition, M-3) and after (postoperative
condition, M+3) STN DBS in Parkinson’s disease patients,
and HC participants
Preoperative
condition
(baseline)
Postoperative
condition
(M+3)
HC group
MeanSD (%) Mean SD (%) Mean SD (%)
Happiness 97.65.9 95.1 6.8 958.2
Sadness 64.2 25.1 59.625 55.624.6
Fear 54.122.2 38.131.9
# 51.3 22.9
Surprise 85.824 87.9 19.2 89 18.6
Disgust 94.678 7 . 4 14.8 89 11.7
Anger 6725.7 5825.9 67 .525.4
No emotion 80.2 24.4 81.3 24.3 85.7 19.4
Total score 83.6 21.6 75.6 10.3
## 76.1 11.4
#P50.05 and
##P50.01when compared with preoperative
condition (Wilcoxon’s test for paired samples).
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ing STN DBS.
Our group had already reported a specific impairment of
fear recognition after STN DBS in Parkinson’s disease
patients (Biseul et al., 2005). We suggested at the time that
this impairment might be a marker of a general associative
or limbic dysfunction following STN DBS, especially in the
OFC. In the present study, we confirmed these previous
results with a different group of patients and provided a
preliminary demonstration in thirteen Parkinson’s disease
patients of a positive correlation between decreased glucose
metabolism, mainly in the right OFC (BA: 10, 11, 47), and
impaired RFE for fear.
The postoperative PET scans were performed 3 months
after surgery, so that we could exclude the microlesional
effects due to STN implantation related in Hilker et al.’s
study (Hilker et al., 2004) where no clusters with significant
differences were found between FDG-pre- versus post-
operative-STN DBS off 3.81.8 months after implantation.
The metabolic cortical modifications following STN DBS
found in our study suggest that the STN region influences
widespread cortical projection areas. The STN is described as
occupying a central position in each of the five corticobasal
ganglia-thalamocortical circuits, which have specific motor,
occulomotor, associative or limbic functions (Alexander
et al., 1990). Animal neuroanatomical studies have demon-
strated that the STN can be functionally divided into
sensorimotor (dorsolateral), limbic (medial) and cognitive-
associative (ventromedial) areas (Parent and Hazrati, 1995;
Joel and Weiner, 1997). Several clinical studies (for a review,
see Temel et al., 2006) have shown that modulating neuronal
activity in the STN results in substantial improvements in
pathological motor behaviour, but may be accompanied
by behavioural changes. Different aspects of behaviour have
A
B
Fig. 1 Statistical parametric maps displaying differences between cerebral glucose metabolism of patients with STN DBS in pre- versus
post-operative on-stimulation conditions. Significant differences (two-tailed P50.005, k4100) are shown on three orthogonal views.
(A) areas with decrease glucose metabolism in postoperative on-stimulation conditions; (B) areas with increase glucose metabolism
in postoperative on-stimulation conditions.
Table 5 Regions of positive correlation between fear RFE and changes in glucose metabolism (P50.005, corrected
for multiple comparison, k4100)
Regions BA Talairach coordinates T-value Cluster size
XY Z
Right frontal lobe, orbital gyrus BA11 9 37 27 5.17 1751
Left frontal lobe, orbital gyrus BA11 43 627 4.64 1751
Right frontal lobe, orbital gyrus BA 47 16 32 25 4.97 1751
Left frontal lobe, middle frontal gyrus BA 46 46 47 7 3.68 1086
Left frontal lobe, inferior frontal gyrus BA 47 36 31 54 . 0 41 0 8 6
Left frontal lobe, inferior frontal gyrus BA 45 57 25 2 3.64 1086
Right frontal lobe, orbital gyrus BA10 10 52 93 . 1 5 1 7 5 1
BA = Brodmann area.
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functions being affected. All the data presented in these
studies underline the potent regulatory function of the STN
in processing associative and limbic information sent to
cortical and subcortical regions. Although the motor
neurones (dorsolateral territory) are the target of functional
surgery, these data indicate that other territories are also
affected. The very small size of the STN (10mm in the
mediolateral axis, 8mm in the anteroposterior axis and 6mm
in the ventrodorsal axis) could account for current diffusion
and for the active effects of stimulation on territories other
than the motor one (Dujardin et al., 2004b).
This hypothesis has also been confirmed by neuroimaging
studies. In a
15O-H2O-PET study, impaired task perfor-
mances (Stroop task) were associated with decreased activa-
tion in both the right anterior cingulate cortex and the
right ventral striatum during STN stimulation, this decreased
activation providing direct evidence of STN modulation
of non-motor basal ganglia-thalamocortical circuitry
(Schroeder et al., 2002). Similarly, decreased frontal activity
during STN stimulation was found to be associated with poor
performances on the fluency task (Schroeder et al., 2003).
In a
18F-FDG-PET study, in the STN DBS on-condition,
clusters of significantly increased glucose metabolism were
found in the right frontal lobe, corresponding to the dorso-
lateral pre-frontal cortex (BA 9) and the OFC (BA 47), the
right middle temporal gyrus (BA 21), the right posterior
cingulate (BA 31) and the left anterior cingulate (BA 32).
In the subcortical regions, bilateral clusters of signifi-
cantly increased glucose metabolism comprised both lower
Fig. 2 Regions with significantly positive correlations (green)
and negative correlations (red) between changes in glucose
metabolism and fear RFE following STN DBS, as measured
with SPM2 (P50.005 on cluster level).Three dimensional
surface projection.
Fig. 3 Significantly positive correlations between changes in the
glucose metabolism of the OFC and changes in fear RFE following
STN DBS (P50.005 on cluster level corrected for multiple
comparisons, colour bar represents t-values).Transversal, sagittal
and coronal views in projection into brain slices of a standard
MRI (x/y/zTalairach coordinates).
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played by the STN in associative and limbic basal ganglia
circuits (Hilker et al., 2003).
Our previous neuropsychological results showed that
fear recognition was selectively impaired, although both
Dujardin et al. (2004b) and Schroeder et al. (2004) reported a
much broader decoding deficit, covering sadness and anger as
well. Using functional resonance magnetic imaging (fMRI),
Sprengelmeyer et al. (1998) demonstrated that RFE of disgust,
fear and anger is based on separate neural systems. Previous
neuroimaging and neuropsychological studies have investi-
gated the neural substrates that mediate responses to fearful
expressions. The right hemisphere plays a role in emotional
and social processing, encompassing perception as well
as recognition. In patients with right hemisphere lesions,
Adolphs et al. (1996) found that recognition of all emotional
expressions was impaired, but that recognition of fear was
the most impaired of all. This specialization of the right
hemisphere for mood and behavioural regulation was subse-
quently described by (Adolphs, 2002a). A large number of
different structures are involved in recognizing facially
expressed emotion. The OFC also seems to be a key structure
when it comes to processing this emotion (Adolphs, 2002a).
Damage to the OFC, especially the right side, can result in
impaired recognition of facial expressions, especially expres-
sions of fear (Adolphs, 2002b). A study by Hornak et al.
(1996) was the first to explicitly demonstrate impaired recog-
nition of facial expressions following damage to the OFC.
Their patients had unilateral and bilateral damage to medial
and lateral aspects of the orbital cortex, and right unilateral
damage was much more frequently associated with impaired
emotion recognition. Marinkovic et al. (2000) found that
surgically removing the right anterior inferior pre-frontal
cortex for intractable epilepsy produced a profound deficit
in recognizing the facial expression of fear, although the
recognition of other facial expressions appeared to be intact.
This type of deficit is also seen in patients with right pre-
frontal lesions (Adolphs et al., 1996). These results suggest
that STN DBS brings about modifications to the orbitofrontal
circuit, and we took this as our ‘a priori’ hypothesis for
our statistical analysis. This confirmed that changes in glucose
metabolism correlated with cognitive impairment mainly
occur in the right hemisphere and the right OFC. Nerverthe-
less, the fact that we studied Parkinsonian brains means that
we can make only limited speculations about the role of the
STN and OFC in RFE in normal brains, although it is worth
noting that our Parkinson’s disease patients had a satisfactory
neuropsychological status and their preoperative MRI scans
were normal (Welter et al., 2002). Moreover, the presence of
emotional disturbances in Parkinson’s disease is still a matter
for debate (Adolphs et al., 1998; Dujardin et al., 2004a).
In the present study, modifications in glucose metabolism
were observed in brain areas other than the OFC, in particular
the amygdala with negative correlation between changes
in glucose metabolism and changes in RFE. Recent studies
have suggested abnormal functioning of the amygdala in
Parkinson’s disease using an RFE paradigm (Yoshimura et al.,
2005). Several studies have described the amygdala as a
structure involved in the rapid, coarse perceptual processing
of facial expressions (Blair and Curran, 1999; Adolphs et al.,
2002). Blair and Curran (1999) showed that the amygdala
Table 6 Regions of negative correlation between fear RFE and changes in glucose metabolism
Regions BA Talairach coordinates T-value Cluster size
XYZ
Right posterior cerebellum 46 73 25 4.15 567
Left parahippocampal gyrus, amygdala 22 0 12 3.01 40

Right temporal lobe, superior temporal gyrus BA 39 44 55 27 4.34 886
Right temporal lobe, fusiform gyrus BA 40 67 49 23 3.42 886
Right temporal lobe, superior gyrus BA 22 67 56 14 3.03 886
P50.005 corrected for multiple comparison, k4100,
P50.005 corrected for multiple comparison, k430.
BA=Brodmann area.
Fig. 4 Significantly negative correlation between changes in the
glucose metabolism of the amygdala and changes of fear RFE
following STN DBS (P50.005 on cluster level corrected for
multiple comparisons, colour bar represents t-values).Transversal,
sagittal and coronal views in projection into brain slices of a
standard MRI (x/y/z coordinates according toTalairach atlas).
1606 Brain (2008),131,1 5 99^ 1 608 F .L.Je uneet al.responds to sad and fearful expressions. Our results suggest
that the STN may modify amygdala activity, although direct
interconnections between these two structures have never
been proven, either in animals or in humans. For the first
time, therefore, we have been able to demonstrate the exist-
ence of interconnections between the amygdala and the STN,
albeit probably indirect ones, passing through the OFC,
as recently suggested by Ghashghaei et al. (2007). In addition,
on the basis of recent findings (Grandjean et al., 2007)
suggesting a functional synchrony between the OFC and the
amygdala, we can speculate that STN DBS is responsible for
a desynchronization of these two structures.
To conclude, our results, demonstrating a correlation
between reduced RFE for fear and changes in the glucose
metabolism of Parkinson’s disease patients under bilateral
STN DBS, confirm—in humans—the role of the STN as a key
basal ganglia structure in associative and limbic circuitry.
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